Keyphrases
Personalized Medication
100%
Drug Response Prediction
100%
Clinical Information
33%
Mutation Status
33%
Epidermal Growth Factor Receptor-tyrosine Kinase Inhibitor (EGFR-TKI)
33%
Tyrosine Kinase Inhibitor
16%
Demographic Information
16%
Simulation-based Learning
16%
XGBoost Classifier
16%
Target Binding
16%
Erlotinib
16%
Quality of Survival
16%
Clinical Genomics
16%
Drug Resistance
16%
Unique mutation
16%
Drug-target Complex
16%
Patient mutations
16%
Medicine and Dentistry
Drug Response
100%
Epidermal Growth Factor Receptor Kinase Inhibitor
28%
Drug Resistance
14%
Tyrosine-Kinase Inhibitor
14%
Erlotinib
14%
Fatality
14%
Pharmacology, Toxicology and Pharmaceutical Science
Epidermal Growth Factor Receptor Kinase Inhibitor
50%
Erlotinib
25%
Gefitinib
25%
Drug Resistance
25%
Clinical Feature
25%
Protein Tyrosine Kinase Inhibitor
25%
Biochemistry, Genetics and Molecular Biology
Receptor Tyrosine Kinase Inhibitors
28%
Clinical Genomics
14%
Erlotinib
14%
Tyrosine Kinase Inhibitor
14%